Immunostaining in Mohs micrographic surgery: A review

Dermatologic Surgery

Volumn 36, Issue 3, 2010, Pages 275-290

  El Tal, Abdel Kader ^a   Abrou, Ayad E ^b   Stiff, Mark A ^a,c   Mehregan, David A ^a,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b Beacon Hill Dermatology   (United States)

^c Skin Cancer Center of Southeast Michigan   (United States)

^d Pinkus Dermatopathology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ACTIN; AMMONIUM SULFATE; ANTIBODY; ANTIGEN; BLOCKING AGENT; CALCIUM; CARCINOEMBRYONIC ANTIGEN; CD34 ANTIGEN; CYTOKERATIN 14; CYTOKERATIN 15; CYTOKERATIN 17; CYTOKERATIN 5; DESMIN; DESMOGLEIN; ENZYME; EOSIN; GLYCOPROTEIN; HEMATOXYLIN; HORSERADISH PEROXIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELAN A; MONOCLONAL ANTIBODY HMB 45; MYOD1 PROTEIN; PARAFFIN; PEROXIDASE; PROTEIN S 100; UNINDEXED DRUG; VIMENTIN;

ABDOMEN; ACINAR CELL; AIR; APOCRINE GLAND; ASTROCYTOMA; BASAL CELL CARCINOMA; BOWEN DISEASE; BREAST; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL GRANULE; CELL LINE; CELL PROLIFERATION; CHEEK; CHEMOSURGERY; CORNEA EPITHELIUM; COW; CYTOPLASM; CYTOSKELETON; DENDRITIC CELL; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; ENDOTHELIUM; EPENDYMOMA; EPIDERMIS CELL; FALSE POSITIVE RESULT; FIBROMATOSIS; FIBROXANTHOMA; FOLLOW UP; FROZEN SECTION; HAIR FOLLICLE; HEAT; HEATING; HEMATOPOIETIC STEM CELL; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; JOINT CAPSULE; KELOID; KERATOACANTHOMA; LANGERHANS CELL; LICHEN PLANUS; LYMPH NODE; LYMPHOCYTIC INFILTRATION; LYMPHOEPITHELIOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT LENTIGO; MEDICARE; MEDLINE; MELANOCYTE; MELANOMA; MELANOSOME; MESENCHYMAL STEM CELL; MICROSCOPY; MOLECULAR WEIGHT; NERVE; NEURILEMOMA; NONHUMAN; PAGET SKIN DISEASE; PRIORITY JOURNAL; REHYDRATION; REIMBURSEMENT; RETICULUM CELL; REVIEW; RHABDOMYOSARCOMA; SCAR; SENSITIVITY AND SPECIFICITY; SKIN; SKIN CELL; SPINDLE CELL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; SUN EXPOSURE; SURVIVAL RATE; SWEAT GLAND; SYSTEMATIC REVIEW; TRICHOEPITHELIOMA; TUMOR CELL;

ANTIGENS, NEOPLASM; DERMATOFIBROSARCOMA; FROZEN SECTIONS; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MELANOMA; MOHS SURGERY; NEOPLASM PROTEINS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 77749240197     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01432.x     Document Type: Review

References (76)

1. Mohs FE. Chemosurgery for melanoma. Arch Dermatol 1977 113 : 285 291.
2. Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol 2005 52 : 295 300.
3. Wildemore JK, Lee JB, Humphreys TR. Mohs surgery for malignant eccrine neoplasms. Dermatol Surg 2004 30 (12 Pt 2) : 1574 1579.
4. Garrett AB, Azmi FH, Ogburia KS. Trichilemmal carcinoma: a rare cutaneous malignancy: a report of two cases. Dermatol Surg 2004 30 : 113 115.
5. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002 47 : 885 892.
6. Snow SN, Larson PO, Lucarelli MJ, et al. Sebaceous carcinoma of the eyelids treated by Mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 2002 28 : 623 631.
7. Seavolt M, McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with Mohs micrographic surgery. Dermatol Surg 2006 32 : 435 441.
8. Brown MD, Swanson NA. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989 15 : 1287 1292.
9. Nelson RA, Arlette JP. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients. Ann Plast Surg 2008 60 : 667 672.
10. Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001 44 : 656 659.
11. Hendi A, Brodland DG, Zitelli JA. Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 2004 51 : 767 773.
12. Dhawan SS, Wolf DJ, Rabinovitz HS, Poulos E. Lentigo maligna. The use of rush permanent sections in therapy. Arch Dermatol 1990 126 : 928 930.
13. Stonecipher MR, Leshin B, Patrick J, White WL. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections. J Am Acad Dermatol 1993 29 : 589 594.
14. Zachary CB, Rest EB, Furlong SM, et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994 20 : 530 535.
15. Harris DW, Kist DA, Bloom K, Zachary CB. Rapid staining with carcinoembryonic antigen aids limited excision of extramammary Paget's disease treated by Mohs surgery. J Dermatol Surg Oncol 1994 20 : 260 264.
16. Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol 1995 32 : 89 94.
17. Robinson JK. A review of immunohistochemical techniques for cutaneous carcinoma. Adv Dermatol 1987 2 : 187 205.
18. Mondragon RM, Barrett TL. Current concepts: the use of immunoperoxidase techniques in mohs micrographic surgery. J Am Acad Dermatol 2000 43 (1 Pt 1) : 66 71.
19. Shafir R, Hiss J, Tsur H, Bubis JJ. Pitfalls in frozen section diagnosis of malignant melanoma. Cancer 1983 51 : 1168 1170.
20. Little JH, Davis NC. Frozen section diagnosis of suspected malignant melanoma of the skin. Cancer 1974 34 : 1163 1172.
21. Cohen LM, McCall MW, Hodge SJ, et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer 1994 73 : 2964 2970.
22. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991 24 : 102 106.
23. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997 37 (2 Pt 1) : 236 245.
24. Ruiter DJ, Bröcker EB. Immunohistochemistry in the evaluation of melanocytic tumors. Semin Diagn Pathol 1993 10 : 76 91.
25. Gross EA, Andersen WK, Rogers GS. Mohs micrographic excision of lentigo maligna using Mel-5 for margin control. Arch Dermatol 1999 135 : 15 7.
26. Chiamenti AM, Vella F, Bonetti F, et al. Anti-melanoma monoclonal antibody HMB-45 recognizes a 30-35 kDa melanosome-associated sialated glycoprotein. Melanoma Res 1996 6 : 291 298.
27. Kikuchi A, Shimizn H, Nishikawa T. Expression and ultrastructural localization of HMB-45 antigen. Br J Dermatol 1996 135 : 400 405.
28. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000 26 : 771 784.
29. Anstey A, Cerio R, Ramnarian N, et al. Desmoplastic malignant melanoma: an immunohistochemical study of 25 cases. Am J Dermatopathol 1994 16 : 14 22.
30. Vijayasaradhi S, Houghton AN. Purification of an autoantigenic 75 kDa human melanosomal glycoprotein. Int J Cancer 1991 47 : 298 303.
31. Thomson TM, Real FX, Murakami S, et al. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol 1988 90 : 459 466.
32. Bhawan J. MEL-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections. Melanoma Res 1997 7 : 43 8.
33. Thomson TM, Mattes MJ, Roux L, et al. Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with mouse monoclonal antibody. J Invest Dermatol 1985 85 : 169 174.
34. Busam KJ, Chen YT, Old LJ, et al. Expression of Melan-A (MART-1) in benign melanocytic nevi and primary cutaneous melanoma. Am J Surg Pathol 1998 22 : 976 982.
35. Jungbluth AA, Busam KJ, Gerald WL, et al. A103: an anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissue. Am J Surg Pathol 1998 22 : 595 602.
36. Chen YT, Stockert E, Jungbluth A, et al. Serological analysis of Melan-A (MART-1), a melanocyte specific protein homogeneously expressed in human melanomas. Proc Natl Acad Sci USA 1996 93 : 5915 5919.
37. Coulie PG, Brichard V, Van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994 180 : 35 42. (Pubitemid 24181053)
38. Saranton T, Chi DD, Garrison DA, et al. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 1997 57 : 1371 1376.
39. Fetsch PA, Cormier J, Hijazi YM. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas. J Immunother 1997 20 : 60 4.
40. de Vries TJ, Fowrkowr A, Wobbes T, et al. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 1997 57 : 3223 3229.
41. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohistochemical staining of the novel antibody Melan-A with S-100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998 32 : 139 146.
42. Cormier JN, Hyazi YM, Abati A, et al. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer 1998 75 : 517 524.
43. Wick MR. Immunohistologic features of melanocytic neoplasms. In : Dabbs DJ, editor. Diagnostic Immunohistochemistry. Philadelphia, PA : Churchill Livingstone 2002. p. 147 162.
44. Griego RD, Zitelli JA. Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma. Dermatol Surg 1998 24 : 1003 1006.
45. Menaker GM, Chiang JK, Tabila B, Moy RL. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma. J Am Acad Dermatol 2001 44 : 833 836.
46. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000 26 : 771 784.
47. Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg 2006 32 : 690 696.
48. Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002 46 : 78 84.
49. Albertini JG, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002 28 : 656 665.
50. Bricca GM, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol Surg 2004 30 : 403 408.
51. Kimyai-Asadi A, Ayala GB, Goldberg LH, et al. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections. Dermatol Surg 2008 34 : 498 500.
52. Alessi E, Venegoni L, Fanoni D, Berti E. Cytokeratin profile in basal cell carcinoma. Am J Dermatopathol 2008 30 : 249 255.
53. Moll R, Moll I, Franke WW. Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 1984 276 : 349 363.
54. Perkins W, Campbell I, Leigh IM, MacKie RM. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. J Cutan Pathol 1992 19 : 476 482.
55. Markey AC, Lane EB, Macdonald DM, Leigh IM. Keratin expression in basal cell carcinomas. Br J Dermatol 1992 126 : 154 160.
56. Markey AC, Lane EB, Churchill LJ, et al. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol 1991 97 : 763 770.
57. Robinson JK, Gottschalk R. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Improved sensitivity for detecting epidermal cancer cells. Arch Dermatol 1984 120 : 199 203.
58. Robinson JK. Expression of keratin proteins in deeply invasive basal and squamous cell carcinoma: an immunohistochemical study. J Dermatol Surg Oncol 1987 13 : 283 294.
59. Setoyama M, Hashimoto K, Dinehart SM, et al. Immunohistochemical differentiation of basal cell epithelioma from cutaneous appendages using monoclonal anti-glycoprotein antibody TNKH1. Its application in Mohs' micrographic surgery. Cancer 1990 66 : 2533 2540.
60. Tellechea O, Reis JP, Domingues JC, Baptista AP. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 1993 15 : 452 455.
61. Kist D, Perkins W, Christ S, Zachary CB. Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation. Dermatol Surg 1997 23 : 1067 1070.
62. Jimenez FJ, Burchette JL Jr., Grichnik JM, Hitchcock MG. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995 8 : 854 858.
63. Krunic AL, Garrod DR, Viehman GE, et al. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation. Dermatol Surg 1997 23 : 463 468.
64. Leshin B, White WL. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited. Arch Dermatol 1990 126 : 900 906.
65. Krunic AL, Garrod DR, Madani S, et al. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin. Br J Cancer 1998 77 : 1275 1279.
66. Smola MG, Soyer HP, Scharnagl E. Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature. Eur J Surg Oncol 1991 17 : 447 453.
67. Robinson JK. Dermatofibrosarcoma protuberans resected by Mohs' surgery (chemosurgery). A 5-year prospective study. J Am Acad Dermatol 1985 12 : 1093 1098.
68. Jimenez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol 1994 20 : 687 689.
69. Garcia C, Viehman G, Hitchcock M, Clark RE. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability. Dermatol Surg 1996 22 : 177 179.
70. Smith SB, Farley MF, Albertini JG, Elston DM. Mohs micrographic surgery for granular cell tumor using S-100 immunostain. Dermatol Surg 2002 28 : 1076 1078.
71. Albertini JG, Welsch MJ, Conger LA, et al. Infantile digital fibroma treated with Mohs micrographic surgery. Dermatol Surg 2002 28 : 959 961.
72. Marra DE, Schanbacher CF, Torres A. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control. Dermatol Surg 2004 30 : 799 802.
73. Jimenez F, Clark RE, Buchanan MD, Kamino H. Lymphoepithelioma-like carcinoma of the skin treated with Mohs micrographic surgery in combination with immune staining for cytokeratins. J Am Acad Dermatol 1995 32 (5 Pt 2) : 878 881.
74. Allee JE, Cotsarelis G, Solky B, Cook JL. Multiply recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. Dermatol Surg 2003 29 : 886 889.
75. Hardaway CA, Graham BS, Barnette DJ, Feldman BD. Embryonal rhabdomyosarcoma presenting in an adult: a case report and discussion of immunohistochemical staining. Am J Dermatopathol 2003 25 : 45 52.
76. Robinson JK. Current histologic preparation methods for Mohs micrographic surgery. Dermatol Surg 2001 27 : 555 560.